Cancer Treatment Services Hyderabad Profile
Key Indicators
- Authorised Capital ₹ 460.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 410.94 Cr
as on 17-07-2024
- Company Age 18 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 166.82 Cr
as on 17-07-2024
- Revenue 18.12%
(FY 2023)
- Profit -16.74%
(FY 2023)
- Ebitda 401.45%
(FY 2023)
- Net Worth -17.19%
(FY 2023)
- Total Assets 17.16%
(FY 2023)
About Cancer Treatment Services Hyderabad
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 460.00 Cr and a paid-up capital of Rs 410.94 Cr.
The company has closed loans amounting to ₹166.82 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Cancer Treatment Services Hyderabad Private Limited India is Keshav Sharda as COMPANY SECRETARY. Rastogi Atul and Jason Henne serve as directors at the Company.
- CIN/LLPIN
U85110TG2006PTC051690
- Company No.
051690
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Nov 2006
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Cancer Treatment Services Hyderabad?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Keshav Sharda  | Company Secretary | 01-Jul-2017 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jason Henne  | Director | 19-Aug-2021 | Current |
| Rastogi Atul | Director | 04-May-2021 | Current |
Financial Performance and Corporate Structure Insights of Cancer Treatment Services Hyderabad.
Cancer Treatment Services Hyderabad Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.12% increase. The company also saw a substantial fall in profitability, with a 16.74% decrease in profit. The company's net worth observed a substantial decline by a decrease of 17.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cancer Treatment Services Hyderabad?
In 2023, Cancer Treatment Services Hyderabad had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Artmed Healthcare Private LimitedActive 8 years 5 monthsRastogi Atul and Jason Henne are mutual person
American Institute Of Pathology And Laboratory Sciences Private LimitedActive 17 years 1 monthRastogi Atul and Jason Henne are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 17 Jan 2019 | ₹1.00 M | Satisfied |
Others Creation Date: 07 Dec 2017 | ₹86.00 Cr | Satisfied |
Others Creation Date: 31 Oct 2017 | ₹2.88 Cr | Satisfied |
How Many Employees Work at Cancer Treatment Services Hyderabad?
Cancer Treatment Services Hyderabad has a workforce of 1141 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cancer Treatment Services Hyderabad, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cancer Treatment Services Hyderabad's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
